 |
|
|
 |
|
|
Estera™ Phase I is designed to benefit women during childbearing years. This product contains a patent-pending blend of phytoestrogens, which are plant based compounds that have a mild estrogenic receptor binding effect. |
|
|
|
|
 |
|
|
For women in menopause, Estera Phase II Transitions Formula is one of the first products in the industry to provide a patent-pending combination of ingredients that addresses the primary health concerns of women during perimenopause.
|
|
|
|
|
 |
|
For women in their post-menopause years, Estera Phase III Maintenance Formula is intended for woman in their postmenopausal years. During postmenopause, it is essential for women to understand the impact of normal hormone fluctuations on their quality of life. |
|
|
|
|
